IRLAB Therapeutics AB

Stocks

Delayed Nasdaq Stockholm Other stock markets 15:37:06 11/06/2026 BST			5-day change	1st Jan Change
1.268 ^SEK	+2.42%		+0.32%	-35.63%

06-08	Irlab shares trade ex-rights on Nasdaq Stockholm following rights issue	FW
06-05	IRLAB Therapeutics AB Announces Board Elections, Effective June 5, 2026	CI

Published on 05/07/2025 at 06:00 am BST - Modified on 05/07/2025 at 10:30 am BST

S&P Capital IQ

Presenter Speech
Mattias Vahlne (Attendees)

Welcome to this live broadcasted Q1 presentation by research company, IRLAB Therapeutics.

Presenting today is CEO, Kristina

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

06-08	Irlab shares trade ex-rights on Nasdaq Stockholm following rights issue	FW
06-05	IRLAB Therapeutics AB Announces Board Elections, Effective June 5, 2026	CI
06-05	Irlab rights issue now 91 percent secured	FW
05-06	IRLAB Q1 operating result swings to profit of SEK 10.7 mln	RE
05-06	Irlab reports growth in revenue and operating profit	FW
05-06	IRLAB Therapeutics AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-05	Verisure climbs on earnings, OMXS30 index gains 1.2 percent	FW
05-05	Eight stocks hit new 52-week lows on the Stockholm Stock Exchange so far today	FW
05-05	Irlab launches SEK 68 million rights issue	FW
05-05	Irlab resolves on rights issue, obtains extended loan financing	RE
04-17	Christer Nordstedt Declines Re-Election as Board Member of IRLAB Therapeutics AB	CI
04-17	Irlab proposes two new board members; Chair to step down this autumn	FW
03-17	Irlab to present pirepemat data and AI platform at AD/PD conference	FW
03-04	Irlab Working to Secure Funding for Phase 3 Study of Mesdopetam - fc	FW
02-26	Study progress triggers $3 mln payment for IRLAB	RE